DRUG · Unmapped registry intervention
HS-20093 in combination with Adebrelimab
Find medicine records ·
Find other trials using this name
Clinical trial
Phase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung Cancer
NCT07063407
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedPhase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Shanghai Hansoh Biomedical Co., Ltdlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07063407 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.